Product Information
Dxd is a monoclonal antibody that binds to the epidermal growth factor receptor (EGFR), which is a receptor tyrosine kinase. It inhibits the proliferation of cancer cells by preventing the binding of epidermal growth factor, which is a potent mitogenic factor. Dxd has been shown to be effective in treating epithelial tumors and can also be used for patients with metabolic disorders such as diabetes mellitus. This drug has shown potent antitumor activity in tumor xenografts and may have therapeutic potential against solid tumors.
Chemical properties
Technical inquiry about: 3D-ZNC44033 Dxd
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
